z-logo
open-access-imgOpen Access
Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing
Author(s) -
Stefanie K. Menzies,
Thea Litschka-Koen,
Rebecca J. Edge,
Jaffer Alsolaiss,
Edouard Crittenden,
Steven R. Hall,
Adam Westhorpe,
Brent Thomas,
James Murray,
dusimo Shongwe,
Sara Padidar,
David Lalloo,
Nicholas R. Casewell,
Jonathan Pons,
Robert A. Harrison
Publication year - 2022
Publication title -
plos neglected tropical diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.99
H-Index - 135
eISSN - 1935-2735
pISSN - 1935-2727
DOI - 10.1371/journal.pntd.0010496
Subject(s) - antivenom , snake venom , venom , medicine , viperidae , biology , pharmacology , toxicology , traditional medicine , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here